Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
A type A thymoma which is characterized by an aggressive clinical course (capsular invasion, infiltration of the surrounding tissues) and can metastasize.
Biomarker and diagnostic research for malignant type A thymoma has been reported in the published literature.
No clinical trials have been registered for malignant type A thymoma.
142 publications have been identified in PubMed for malignant type A thymoma. Research spans Case Report / Case Series (46%), Clinical Trial Publication (14%), and Basic Science / Preclinical (13%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 57 | 46% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 4:46 AM UTC
18 |
14% |
Laboratory research | 16 | 13% |
Disease patterns and progression | 14 | 11% |
Testing and diagnosis research | 11 | 9% |
Research summaries | 7 | 6% |
New treatment approaches | 2 | 2% |
González-Ramos K (2026). [PMID: 42005993](https://pubmed.ncbi.nlm.nih.gov/42005993/). *Case Rep Rheumatol*. [Gene Therapy / Novel Therapeutics]
Frasca L (2026). [PMID: 41681802](https://pubmed.ncbi.nlm.nih.gov/41681802/). *Diagnostics (Basel)*. [Basic Science / Preclinical]
Weissferdt A (2026). [PMID: 41580205](https://pubmed.ncbi.nlm.nih.gov/41580205/). *Human pathology*. [Gene Therapy / Novel Therapeutics]
Xie J (2026). [PMID: 41918237](https://pubmed.ncbi.nlm.nih.gov/41918237/). *Ann Med*. [Review / Meta-Analysis]
Sun J (2026). [PMID: 41909655](https://pubmed.ncbi.nlm.nih.gov/41909655/). *Front Immunol*. [Case Report / Case Series]
Zeng H (2026). [PMID: 41925910](https://pubmed.ncbi.nlm.nih.gov/41925910/). *Cancer Immunol Immunother*. [Epidemiology / Natural History]
Lusvarghi IL (2026). [PMID: 41812675](https://pubmed.ncbi.nlm.nih.gov/41812675/). *Arquivos de neuro-psiquiatria*. [Case Report / Case Series]
Fujikura K (2026). [PMID: 41344988](https://pubmed.ncbi.nlm.nih.gov/41344988/). *The Journal of pathology*. [Diagnostic / Biomarker]
Torres Ordonez A (2026). [PMID: 41532900](https://pubmed.ncbi.nlm.nih.gov/41532900/). *JACC. Case reports*. [Case Report / Case Series]
Chanalia V (2026). [PMID: 41928685](https://pubmed.ncbi.nlm.nih.gov/41928685/). *Protein Pept Lett*. [Review / Meta-Analysis]